The European Medicines Agency (EMA) now says there is a “possible link” between the Oxford-AstraZeneca COVID-19 vaccine and rare blood clots. Crystal Goomansingh explains the findings, how some countries are now adjusting their immunization rollouts, and the symptoms that recipients of this vaccine are being told to watch out for.
- COVID-19: 7 more pharmacies offer AstraZeneca vaccine in Barrie, Innisfil
- Concerns over AstraZeneca grow as Australia, Philippines, African Union curb COVID-19 shots
- ‘Possible’ link between AstraZeneca vaccine and rare blood clots, EU drug regulator says